As a number of posters have inferred before, LMB management seem to have two left feet.
It probably doesn't mean much in the grand scheme and the sooner they get something of substance regarding the merger the better we all will be.
- Forums
- ASX - By Stock
- HXG
- Ann: Retraction of Scoping Study Announcement of 24 June 2014
Ann: Retraction of Scoping Study Announcement of 24 June 2014, page-3
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HXG (ASX) to my watchlist
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.180M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.4¢ | $737 | 52.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 48379 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 71400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48379 | 0.014 |
1 | 125000 | 0.013 |
7 | 2753333 | 0.012 |
3 | 1045593 | 0.011 |
3 | 605108 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 71400 | 1 |
0.017 | 195551 | 2 |
0.018 | 250000 | 2 |
0.019 | 15789 | 1 |
0.020 | 9999 | 1 |
Last trade - 14.25pm 15/07/2024 (20 minute delay) ? |
Featured News
HXG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online